EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Hemophagocytic lymphohistiocytosis with a hemizygous PRF1 c.674G>A mutation

Xiangke Xin, Na Wang, Yicheng Zhang

The American Journal of the Medical Sciences · 2023

DOI: 10.1016/j.amjms.2023.07.005 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The American Journal of the Medical Sciences, 2023. Verfasst von Xiangke Xin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemophagocytic lymphohistiocytosis(HLH) is a rare highly-fatal disease presenting with fever, hepatosplenomegaly, and pancytopenia and has a poor prognosis. Homozygous or semi-zygous or complex heterozygous variants can cause familial HLH and heterozygous carriers are frequently seen in secondary HLH. A 42-year-old male patient was admitted to the hospital for persistent fever, fatigue, and splenomegaly. Investigations revealed hypertriglyceridemia, hyperlactatemia dehydrogenaseemia, hyperferritinemia, and elevated levels of soluble cluster of differentiation 25. We found a heterozygous mutation of PRF1: c.674G>A (p.R225Q) through next-generation sequencing technology of hemophagocytic-lymphohistiocytosis-related genes. After a brief remission with dexamethasone and etoposide-based therapy, the disease relapsed quickly, and an allogeneic hematopoietic stem cell transplant was performed to achieve complete remission. To date, the patient's condition was in complete remission. Our study detected a rare missense mutation in the PRF1 gene in a patient with HLH disease and the c.674G>A mutation may be rated as a possible pathogenic variant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphohistiocytosis, HemophagocyticHematopoietic Stem Cell TransplantationMaleHumansAdultPerforinMutationMutation, Missense

Stichwörter der Autor:innen

Allogeneic hematopoietic stem cell transplantationHemophagocytic lymphohistiocytosisHeterozygous mutationPRF1

Substanzen

PerforinPRF1 protein, human

Autor:innen und Institutionen

  • Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Electronic address: yczhang@tjh.tjmu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xin, X., Wang, N., & Zhang, Y. (2023). Hemophagocytic lymphohistiocytosis with a hemizygous PRF1 c.674G>A mutation. The American Journal of the Medical Sciences. https://doi.org/10.1016/j.amjms.2023.07.005

Vancouver

Xin X, Wang N, Zhang Y. Hemophagocytic lymphohistiocytosis with a hemizygous PRF1 c.674G>A mutation. The American Journal of the Medical Sciences. 2023. doi:10.1016/j.amjms.2023.07.005

BibTeX
@article{Xin2023,
  author = {Xin, Xiangke and Wang, Na and Zhang, Yicheng},
  title = {Hemophagocytic lymphohistiocytosis with a hemizygous PRF1 c.674G>A mutation},
  journal = {The American Journal of the Medical Sciences},
  year = {2023},
  doi = {10.1016/j.amjms.2023.07.005}
}
Kostenlos starten →